205 related articles for article (PubMed ID: 38504071)
21. Postoperative chemoradiotherapy vs. preoperative chemoradiotherapy for locally advanced (operable) gastric cancer: clarifying the role and technique of radiotherapy.
Wong RK; Jang R; Darling G
J Gastrointest Oncol; 2015 Feb; 6(1):89-107. PubMed ID: 25642342
[TBL] [Abstract][Full Text] [Related]
22. Interpretation of the development of neoadjuvant therapy for gastric cancer based on the vicissitudes of the NCCN guidelines.
Wang XZ; Zeng ZY; Ye X; Sun J; Zhang ZM; Kang WM
World J Gastrointest Oncol; 2020 Jan; 12(1):37-53. PubMed ID: 31966912
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant immunotherapy in non-small cell lung cancer: a narrative review on mechanisms, efficacy and safety.
Shao L; Lou G
J Thorac Dis; 2022 Sep; 14(9):3565-3574. PubMed ID: 36245597
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of neoadjuvant immunotherapy plus chemotherapy in Chinese surgically resectable gastric cancer: a pilot study by meta-analysis.
Xu H; Li T; Shao G; Wang W; He Z; Xu J; Qian Y; Liu H; Ge H; Wang L; Zhang D; Yang L; Li F; Xu Z
Front Immunol; 2023; 14():1193614. PubMed ID: 37426646
[TBL] [Abstract][Full Text] [Related]
25. Progress in the treatment of advanced gastric cancer.
Song Z; Wu Y; Yang J; Yang D; Fang X
Tumour Biol; 2017 Jul; 39(7):1010428317714626. PubMed ID: 28671042
[TBL] [Abstract][Full Text] [Related]
26. Short-term outcome of neoadjuvant immunotherapy and chemotherapy in non-small cell lung cancer: A systematic review and meta-analysis.
Zhang C; Hong HZ; Wu YL; Zhong WZ
JTCVS Open; 2021 Dec; 8():588-607. PubMed ID: 36004199
[TBL] [Abstract][Full Text] [Related]
27. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
28. Current neoadjuvant therapy for operable locally advanced esophageal cancer.
Yang W; Niu Y; Sun Y
Med Oncol; 2023 Jul; 40(9):252. PubMed ID: 37498350
[TBL] [Abstract][Full Text] [Related]
29. Toripalimab combined with targeted therapy and chemotherapy achieves pathologic complete response in gastric carcinoma: A case report.
Liu R; Wang X; Ji Z; Deng T; Li HL; Zhang YH; Yang YC; Ge SH; Zhang L; Bai M; Ning T; Ba Y
World J Clin Cases; 2022 Jun; 10(18):6184-6191. PubMed ID: 35949814
[TBL] [Abstract][Full Text] [Related]
30. [Controversies and progress in adjuvant chemotherapy for patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy].
Li XX; Li QG
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):594-596. PubMed ID: 31238639
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysis.
Liu Y; Bao Y; Yang X; Sun S; Yuan M; Ma Z; Zhang W; Zhai Y; Wang Y; Men Y; Qin J; Xue L; Wang J; Hui Z
Front Immunol; 2023; 14():1117448. PubMed ID: 36761760
[TBL] [Abstract][Full Text] [Related]
32. Progress in neoadjuvant therapy for gastric cancer.
Su PF; Yu JC
Oncol Lett; 2022 Jun; 23(6):172. PubMed ID: 35497934
[TBL] [Abstract][Full Text] [Related]
33. The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer.
Koerner AS; Moy RH; Ryeom SW; Yoon SS
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627142
[TBL] [Abstract][Full Text] [Related]
34. Safety and feasibility of esophagectomy following combined neoadjuvant immunotherapy and chemotherapy for locally advanced esophageal cancer: a propensity score matching.
Hong ZN; Zhang Z; Chen Z; Weng K; Peng K; Lin J; Kang M
Esophagus; 2022 Apr; 19(2):224-232. PubMed ID: 34988773
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of immunotherapy plus chemotherapy as neoadjuvant treatment for patients with locally advanced gastric cancer: a retrospective cohort study.
Wang X; Huang J; Huang H; Liu Y; Ji C; Liu J
Invest New Drugs; 2023 Aug; 41(4):579-586. PubMed ID: 37368088
[TBL] [Abstract][Full Text] [Related]
36. The role of adjuvant chemotherapy in rectal cancer patients with ypT0-2N0 after neoadjuvant chemoradiotherapy.
Yang J; Deng Q; Chen Z; Chen Y; Fu Z
Front Oncol; 2024; 14():1338098. PubMed ID: 38406812
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): a study protocol of a prospective, single-arm, phase II trial.
Chen J; Han Y; Hu Y; Feng X; Meng X; Guo S; Sun C; Chen G; Li K
BMJ Open; 2023 May; 13(5):e067767. PubMed ID: 37253491
[TBL] [Abstract][Full Text] [Related]
38. Perioperative outcomes of neoadjuvant immunotherapy plus chemotherapy and neoadjuvant chemoradiotherapy in the treatment of locally advanced esophageal squamous cell carcinoma: a retrospective comparative cohort study.
Zhang H; Zhang Z; Yang L; Wu B; Chen Y; He H; Li C; Lin W; Lin J
J Thorac Dis; 2023 Mar; 15(3):1279-1288. PubMed ID: 37065590
[TBL] [Abstract][Full Text] [Related]
39. History and current situation of neoadjuvant treatment for locally advanced esophageal cancer.
Li J; Ma S
Thorac Cancer; 2021 Sep; 12(17):2293-2299. PubMed ID: 34254738
[TBL] [Abstract][Full Text] [Related]
40. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.
Wang X; Li S; Sun Y; Li K; Shen X; Xue Y; Liang P; Li G; Chen L; Zhao Q; Li G; Fu W; Liang H; Xin H; Suo J; Fang X; Zheng Z; Xu Z; Chen H; Zhou Y; He Y; Huang H; Zhu L; Yang K; Ji J; Ye Y; Zhang Z; Li F; Wang X; Tian Y; Park S; Chen L
BMC Cancer; 2021 Jan; 21(1):20. PubMed ID: 33402102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]